The legacy of the contaminated blood scandal continues to exact a heavy toll on victims and their families, as administrative barriers within the Infected Blood Compensation Authority (IBCA) scheme threaten to deny justice to those who have endured decades of suffering. Suzanne Morgan, whose mother Mari died after receiving infected blood during a routine transfusion in 1991, represents countless others caught in a bureaucratic maze. The requirement to scour decades-old medical records to prove eligibility—despite a public inquiry’s recommendation for a “balance of probability” standard—has left victims like Morgan grappling with emotional and logistical exhaustion.
Personal Tragedy Amidst Systemic Failures
Morgan’s mother’s death in hospital, followed by the harrowing revelation of Hepatitis C, marked the beginning of a lifelong struggle. “She went downhill rapidly,” Morgan recalls, her voice steady yet tinged with grief. “I was in total shock. I was hysterical.” The trauma of losing her mother, compounded by the inability to view her body due to contagion protocols, mirrors the experiences of thousands others affected by the scandal. For survivors like Rosie McKearney, whose son Andrew died from complications linked to infected blood products, the pain is compounded by a system that demands proof of past injustices.
The IBCA’s stringent eligibility criteria have been met with fury from campaigners, who argue that the process retraumatises victims while disregarding the public inquiry’s findings. “People feel they are being treated as potential fraudsters rather than victims of one of the greatest scandals in our history,” said Rachel Halford, chief executive of the Hepatitis C Trust. The organisation has documented cases where applicants were required to provide school records, tenancy agreements, or family photographs to establish residency or relationships—a process many find culturally insensitive and practically impossible.
Bureaucratic Burden on Victims
The IBCA’s approach has sparked accusations of institutional insensitivity and a failure to honour commitments made to survivors. Campaigners argue that the “tick box” mentality, driven by the Cabinet Office’s oversight of the scheme, prioritises cost-cutting over compassion. “The Cabinet Office is completely controlling the Infected Blood Compensation Authority scheme. It’s meant to be an independent, arm’s length body,” observed Lynne Kelly, chair of Haemophilia Wales. Critics allege that eligibility criteria are designed to minimise payouts, leaving haemophilia treatment centres to shoulder the burden of forensic record-keeping.
Luke O’Shea, who received an infected clotting product as a child, faces a compensation shortfall of up to £1 million due to the absence of a liver biopsy—a procedure deemed too risky for haemophiliacs. “I wasn’t told I had hepatitis C until I was 15,” he said. “So just as life was beginning to open up, I was suddenly told what had already been done to it.” Such stories underscore the systemic failures that have left survivors navigating a labyrinth of medical history to prove what should be a straightforward claim.
Campaigners Demand Reform
Advocates like Charlotte Evans, a lawyer representing victims, argue that the IBCA’s demand for “beyond reasonable doubt” evidence contradicts the legal standard for medical negligence claims, which operates on a “balance of probabilities” threshold. “Instead of assessing all the available evidence to build up a picture of what most likely happened, applicants are being asked to prove a specific blood product was administered,” she explained. The Haemophilia Society has called for regulatory changes to shift the burden of proof from applicants to the state, ensuring that all individuals with bleeding disorders are compensated unless proven otherwise.
The pressure extends to healthcare professionals, who are reportedly working unpaid weekends to parse through patient records for IBCA inquiries. “This is highly technical work, relying on expert knowledge to find fragments of crucial information, yet centres are expected to fund this themselves,” said Kate Burt, the society’s chief executive. The strain on treatment centres, coupled with the emotional toll on survivors, has galvanized a coalition demanding systemic reform.
Government’s Response and Accountability
Amid mounting criticism, Prime Minister Keir Starmer’s predecessor, Andy Burnham, had long championed victims’ rights. However, recent revelations suggest a dilution of accountability, with responsibility for the scandal shifted from a cabinet-level secretary of state to a junior minister. “As prime minister, we need him to live up to that reputation and the promises he has made,” Halford urged.
The IBCA has defended its processes, stating that missing records will not preclude claims and that evidence can include witness testimony or family documents. A government spokesperson asserted that engagement with the community has informed ongoing adjustments to the scheme. Yet campaigners remain unconvinced, citing slow progress: research by the Haemophilia Society shows that only 15% of claims have been processed since the IBCA’s inception two years ago.
Why it Matters
The ongoing struggles of infected blood scandal victims illuminate a profound failure in public accountability and compassion. By imposing an untenable evidentiary burden, the IBCA risks perpetuating a cycle of injustice that inflicts further pain on individuals already scarred by systemic neglect. The scandal’s legacy is not merely a historical atrocity but a living wound, demanding urgent reforms to restore dignity to those who survived one of Britain’s darkest chapters in healthcare history. The government’s response—or lack thereof—will determine whether justice is served or another generation is denied the closure they deserve.